4th Summer School in Immuno-Oncology, July 1st-3rd, 2021, Athens, Greece.

Cancer biomarkers Cancer immunology Cancer immunotherapy Immune checkpoint inhibitors Immune monitoring Immunomodulatory mechanisms

Journal

Frontiers in bioscience (Landmark edition)
ISSN: 2768-6698
Titre abrégé: Front Biosci (Landmark Ed)
Pays: Singapore
ID NLM: 101612996

Informations de publication

Date de publication:
30 11 2021
Historique:
received: 15 07 2021
revised: 26 07 2021
accepted: 10 08 2021
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 14 1 2022
Statut: ppublish

Résumé

The 4th Summer School in Immuno-Oncology was held from July 1st-July 3rd as a web meeting. Many eminent researchers and leading oncologists from Europe and the USA working on basic, translational and clinical cancer research participated, presented, and discussed the most recent advances in cancer immunology and immunotherapy. Besides sharing the newest information in the field of cancer immunology and immunotherapy, the meeting also focused on the actual translation of new knowledge acquired in the lab to the clinical setting; particular emphasis was given to the mode of action of novel therapeutic modalities and to biomarkers helpful for treatment decision-making, as well as to means that may improve cancer immunotherapeutic protocols used for the treatment of a variety of malignancies. The main topics presented by the speakers included: (1) mechanisms of tumor immune evasion and resistance; (2) host-tumor interactions and means to regulate antitumor immunity; (3) exploitation of new biomarkers and tumor or immune signatures able to potentially guide therapeutic interventions; (4) emerging therapeutic modalities for cancer treatment and specific immunotherapeutics for thoracic, genito-urinary, gastrointestinal, skin and breast cancers; and (5) innovative treatment options and alternatives to minimize the toxic adverse events of cancer immunotherapy.

Identifiants

pubmed: 34856774
pii: s2768-6701(21)00086-1
doi: 10.52586/5030
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1373-1382

Informations de copyright

© 2021 The Author(s). Published by BRI.

Auteurs

Ioannis V Kostopoulos (IV)

Department of Biology, National and Kapodistrian University of Athens, 157 84 Athens, Greece.

Nikolaos Orologas-Stavrou (N)

Department of Biology, National and Kapodistrian University of Athens, 157 84 Athens, Greece.

Nikolaos Angelis (N)

Department of Biology, National and Kapodistrian University of Athens, 157 84 Athens, Greece.

Ioannis S Pateras (IS)

Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, 157 72 Athens, Greece.

Athanasios Kotsakis (A)

Department of Medical Oncology, University Hospital of Larisa, 413 34 Thessaly, Greece.

Vassilis Georgoulias (V)

1st Department of Medical Oncology, Metropolitan General, 155 62 Athens, Greece.

Constantin N Baxevanis (CN)

Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital, 115 22 Athens, Greece.

Graham Pawelec (G)

Department of Immunology, University of Tübingen, Tübingen, Germany & Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada.

Ourania E Tsitsilonis (OE)

Department of Biology, National and Kapodistrian University of Athens, 157 84 Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH